HGI changes private ownership
This article was originally published in Clinica
Executive Summary
Medical device supplier HGI Holdings has been bought by New York-based private investment firms Clayton, Dubilier & Rice and GS Capital Partners. HGI was previously owned by another private equity firm, The Jordan Company and members of the Harrington family. HGI is distributes medical products for chronic disease patients, including devices used in the ostomy, diabetes, urology, enteral, incontinence and wound care markets. HGI consists of two segments: Edgepark Medical Supplies, which provides direct-to-consumer home delivery of products to around 300,000 patients, and Independence Medical, an outsourced supply chain serving around 5,500 commercial customers. Financial terms of the deal were not disclosed.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals